In their anwer to European Medicines Agency (EMEA)'s public consultation, Prescrire and its allies find EMEA's draft transparency policy to be weak and irresponsible. They call for EMEA's full accountability to the public. Real transparency is an indispensable prerequisite to restore EU citizens’ confidence in EMEA’s decisions.
© September 2009
> Click here for the full document "EMEA transparency policy falls short: a weak and irresponsible project", a joint answer by HAI Europe, ISDB and MiEF to "The EMEA transparency policy – draft for public consultation" (pdf, 382 Ko).